ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 75 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $47,000 | -40.5% | 18,264 | -9.9% | 0.00% | – |
| Q3 2016 | $79,000 | +75.6% | 20,265 | +20.7% | 0.00% | – |
| Q2 2016 | $45,000 | +104.5% | 16,788 | +139.9% | 0.00% | – |
| Q1 2016 | $22,000 | -18.5% | 6,998 | 0.0% | 0.00% | – |
| Q4 2015 | $27,000 | +28.6% | 6,998 | 0.0% | 0.00% | – |
| Q3 2015 | $21,000 | 0.0% | 6,998 | +44.0% | 0.00% | – |
| Q2 2015 | $21,000 | -60.4% | 4,860 | -64.3% | 0.00% | – |
| Q1 2015 | $53,000 | -35.4% | 13,602 | +12.2% | 0.00% | – |
| Q4 2014 | $82,000 | +41.4% | 12,125 | +14.6% | 0.00% | – |
| Q3 2014 | $58,000 | -46.3% | 10,583 | 0.0% | 0.00% | – |
| Q2 2014 | $108,000 | -26.5% | 10,583 | -13.7% | 0.00% | – |
| Q1 2014 | $147,000 | +14.8% | 12,267 | +8.2% | 0.00% | – |
| Q4 2013 | $128,000 | +9.4% | 11,334 | +4.8% | 0.00% | – |
| Q3 2013 | $117,000 | +33.0% | 10,818 | +14.0% | 0.00% | – |
| Q2 2013 | $88,000 | – | 9,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
| WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
| Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
| LMR Partners LLP | 148,309 | $319,000 | 0.02% |
| LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
| Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |